Ivo Lukitsch

1.1k total citations
12 papers, 644 citations indexed

About

Ivo Lukitsch is a scholar working on Infectious Diseases, Surgery and Molecular Biology. According to data from OpenAlex, Ivo Lukitsch has authored 12 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Ivo Lukitsch's work include Urticaria and Related Conditions (2 papers), COVID-19 Clinical Research Studies (2 papers) and Organ Transplantation Techniques and Outcomes (2 papers). Ivo Lukitsch is often cited by papers focused on Urticaria and Related Conditions (2 papers), COVID-19 Clinical Research Studies (2 papers) and Organ Transplantation Techniques and Outcomes (2 papers). Ivo Lukitsch collaborates with scholars based in United States, Germany and Australia. Ivo Lukitsch's co-authors include Duska Dragun, Friedrich C. Luft, Muner Mohamed, Cesar F. Hernandez-Arroyo, Aldo Torres‐Ortiz, Vipin Varghese, Juan Carlos Q. Velez, Dominik N. Müller, Stefan G. Tullius and Gabriela Riemekasten and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Annals of the Rheumatic Diseases.

In The Last Decade

Ivo Lukitsch

11 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivo Lukitsch United States 7 194 164 155 147 121 12 644
Vincent Pernin France 11 106 0.5× 216 1.3× 34 0.2× 35 0.2× 115 1.0× 29 623
Yoichi Kakuta Japan 17 315 1.6× 141 0.9× 26 0.2× 67 0.5× 101 0.8× 96 845
Μaria Stangou Greece 17 84 0.4× 506 3.1× 42 0.3× 155 1.1× 212 1.8× 90 972
Mazen Arar United States 14 133 0.7× 313 1.9× 27 0.2× 94 0.6× 45 0.4× 25 923
Umut Selda Bayrakçı Türkiye 13 81 0.4× 189 1.2× 29 0.2× 28 0.2× 107 0.9× 59 510
Takeshi Fujita Japan 12 74 0.4× 86 0.5× 21 0.1× 31 0.2× 83 0.7× 47 421
Umut Selamet United States 14 58 0.3× 236 1.4× 18 0.1× 83 0.6× 112 0.9× 40 842
Tadashi Sofue Japan 12 89 0.5× 328 2.0× 17 0.1× 75 0.5× 77 0.6× 52 540
Kerstin Benz Germany 15 69 0.4× 411 2.5× 18 0.1× 116 0.8× 174 1.4× 44 851
Marta Lapsley United Kingdom 18 102 0.5× 362 2.2× 86 0.6× 281 1.9× 19 0.2× 26 1.1k

Countries citing papers authored by Ivo Lukitsch

Since Specialization
Citations

This map shows the geographic impact of Ivo Lukitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivo Lukitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivo Lukitsch more than expected).

Fields of papers citing papers by Ivo Lukitsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivo Lukitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivo Lukitsch. The network helps show where Ivo Lukitsch may publish in the future.

Co-authorship network of co-authors of Ivo Lukitsch

This figure shows the co-authorship network connecting the top 25 collaborators of Ivo Lukitsch. A scholar is included among the top collaborators of Ivo Lukitsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivo Lukitsch. Ivo Lukitsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Velez, Juan Carlos Q., Muner Mohamed, Swetha Rani Kanduri, et al.. (2024). Addition of a Loop Diuretic to Norepinephrine During Treatment of Hepatorenal Syndrome Type 1. Kidney International Reports. 10(2). 466–474. 1 indexed citations
2.
3.
Mohamed, Muner, Ivo Lukitsch, Aldo Torres‐Ortiz, et al.. (2020). Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans. Kidney360. 1(7). 614–622. 176 indexed citations
4.
Mohamed, Muner, et al.. (2020). Dialysis Filter Life, Anticoagulation, and Inflammation in COVID-19 and Acute Kidney Injury. Kidney360. 1(12). 1426–1431. 14 indexed citations
5.
Lukitsch, Ivo, et al.. (2020). Markers of Inflammation and Risk for AKI and Need for Dialysis in Patients with COVID-19. Journal of the American Society of Nephrology. 31(10S). 258–259. 1 indexed citations
6.
Lukitsch, Ivo, Lyubov Chaykovska, Gerd Wallukat, et al.. (2012). Renal Ischemia and Transplantation Predispose to Vascular Constriction Mediated by Angiotensin II Type 1 Receptor-Activating Antibodies. Transplantation. 94(1). 8–13. 51 indexed citations
7.
Buell, Joseph F., Mary Killackey, Rubin Zhang, et al.. (2012). Successful transplantation of HIV patients: the Louisiana experience.. PubMed. 164(4). 191–3. 4 indexed citations
8.
Riemekasten, Gabriela, Aurélie Philippe, Torsten Slowinski, et al.. (2010). Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Annals of the Rheumatic Diseases. 70(3). 530–536. 212 indexed citations
9.
Hoff, Uwe, Ivo Lukitsch, Lyubov Chaykovska, et al.. (2010). Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury. Kidney International. 79(1). 57–65. 63 indexed citations
10.
11.
Dragun, Duska, Stefan G. Tullius, Joon Keun Park, et al.. (1998). ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney International. 54(2). 590–602. 84 indexed citations
12.
Dragun, Duska, Ivo Lukitsch, Stefan G. Tullius, et al.. (1998). Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat. Kidney International. 54(6). 2113–2122. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Pernin Breakdown of academic impact, for papers by Yoichi Kakuta Breakdown of academic impact, for papers by Μaria Stangou Breakdown of academic impact, for papers by Mazen Arar Breakdown of academic impact, for papers by Umut Selda Bayrakçı Breakdown of academic impact, for papers by Takeshi Fujita Breakdown of academic impact, for papers by Umut Selamet Breakdown of academic impact, for papers by Tadashi Sofue Breakdown of academic impact, for papers by Kerstin Benz Breakdown of academic impact, for papers by Marta Lapsley
Rankless by CCL
2026